Menard Financial Group’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-2,169
Closed -$651K 174
2024
Q4
$651K Buy
2,169
+14
+0.6% +$4.89K 0.39% 55
2024
Q3
$876K Buy
2,155
+21
+1% +$7.69K 0.58% 38
2024
Q2
$686K Buy
2,134
+40
+2% +$13K 0.49% 45
2024
Q1
$699K Buy
2,094
+537
+34% +$164K 0.59% 36
2023
Q4
$422K Buy
1,557
+273
+21% +$67.5K 0.52% 47
2023
Q3
$316K Buy
+1,284
New +$351K 0.46% 53

Other funds holding HCA

Menard Financial Group's HCA Position: Q1 2025 in Review

Menard Financial Group sold out of HCA Healthcare (HCA) in Q1 2025, closing a stake of 2,169 shares — an estimated $651K sold.

Menard Financial Group first reported a position in HCA in Q3 2023 and held it in 6 quarters. The position peaked at $876K in Q3 2024. 1,224 funds tracked by Wall St. Rank hold HCA as of Q1 2025.

  • Menard Financial Group reported no remaining HCA Healthcare position as of Q1 2025 after selling out during the quarter.
  • Menard Financial Group sold 2,169 HCA Healthcare shares in Q1 2025, an estimated $651K.
  • Menard Financial Group first reported a position in HCA Healthcare in Q3 2023 and held it in 6 quarters.
  • Menard Financial Group's HCA Healthcare position peaked at $876K in Q3 2024.
  • 1,224 funds tracked by Wall St. Rank held HCA Healthcare as of Q1 2025.

Based on Menard Financial Group's 13F filing for Q1 2025, filed 8 May 2025.